Advanced search
Publication Cover
Aging Health Volume 2, 2006 - Issue 3
Journal homepage
42
Views
0
CrossRef citations to date
0
Altmetric
Review

Parkinson’s Disease and Deep Brain Stimulation

Rianne AJ Esselink1 Department of Neurology, Academic Medical Center Amsterdam, PO Box 22660, 1100DDAmsterdam, The Netherlands Tel.: +31 (0)20 5663842; Fax: +31 (0)20 5669374; E-mail: [email protected]@amc.uva.nl;2 Departments of Neurology and Geriatrics, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500HBNijmegen, The Netherlands. Tel.: +31 (0)24 3618860; Fax: +31 (0)24 3541122; E-mail: [email protected]
,
Rob MA de Bie1 Department of Neurology, Academic Medical Center Amsterdam, PO Box 22660, 1100DDAmsterdam, The Netherlands Tel.: +31 (0)20 5663842; Fax: +31 (0)20 5669374; E-mail: [email protected]@amc.uva.nl
,
P Richard Schuurman3 Department of Neurosurgery, Academic Medical Center Amsterdam, PO Box 22660, 1100DDAmsterdam, The Netherlands Tel.: +31 (0)20 5663542; Fax: +31 (0)20 5669590; E-mail: [email protected]@amc.uva.nl
,
D Andries Bosch3 Department of Neurosurgery, Academic Medical Center Amsterdam, PO Box 22660, 1100DDAmsterdam, The Netherlands Tel.: +31 (0)20 5663542; Fax: +31 (0)20 5669590; E-mail: [email protected]@amc.uva.nl
&
Johannes D Speelman1 Department of Neurology, Academic Medical Center Amsterdam, PO Box 22660, 1100DDAmsterdam, The Netherlands Tel.: +31 (0)20 5663842; Fax: +31 (0)20 5669374; E-mail: [email protected]@amc.uva.nl
Pages 473-487 | Published online: 24 May 2006

Bibilography

  • Parkinson J: An essay on the shaking palsy. Sherwood, Neely and Jones, London, UK (1817).
  • Moghal S , RajputAH, D‘ArcyC, Rajput R: Prevalence of movement disorders in elderly community residents. Neuroepidemiology13(4), 175–178(1994).
  • de Rijk MC , BretelerMM, GravelandGAet al.: Prevalence of Parkinson‘s disease in the elderly: the Rotterdam Study. Neurology45(12), 2143–2146(1995).
  • Gelb DJ , OliverE, GilmanS: Diagnostic criteria for Parkinson disease.Arch. Neurol.56(1), 33–39(1999).
  • Gibb WR , LeesAJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson‘s disease.J. Neurol. Neurosurg. Psychiatr.51(6), 745–752(1988).
  • Hughes AJ , DanielSE, Ben-ShlomoY, Lees AJ: The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain125(4), 861–870(2002).
  • Hoehn MM , YahrMD: Parkinsonism: onset, progression and mortality.Neurology17(5), 427–442(1967).
  • Maier Hoehn MM : Parkinson‘s disease: progression and mortality. In:Advances in Neurology. Yahr MD, Bergmann KJ (Eds). Raven Press, NY, USA, 457–461(1986).
  • Marttila RJ : Epidemiology. In:Handbook of Parkinson‘s Disease (2 Edition). Koller WC (Ed.). Marcel Dekker Inc, NY, USA, 35–57(1992).
  • Hely MA , MorrisJG, TraficanteR, ReidWG, O‘SullivanDJ, WilliamsonPM: The sydney multicentre study of Parkinson‘s disease: progression and mortality at 10 years.J. Neurol. Neurosurg. Psychiatr.67(3), 300–307(1999).
  • Albin RL , YoungAB, PenneyJB: The functional anatomy of basal ganglia disorders.Trends Neurosci.12(10), 366–375(1989).
  • Alexander GE , CrutcherMD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing.Trends Neurosci.13(7), 266–271(1990).
  • DeLong MR : Primate models of movement disorders of basal ganglia origin.Trends Neurosci.13(7), 281–285(1990).
  • Rascol O , GoetzC, KollerW, PoeweW, SampaioC: Treatment interventions for Parkinson‘s disease: an evidence based assessment.Lancet359(4), 1589–1598(2002).
  • Goetz CG , PoeweW, RascolO, SampaioC: Evidence-based medical review update: pharmacological and surgical treatments of Parkinson‘s disease: 2001 to 2004.Mov. Disord.20(5), 523–539(2005).
  • Rascol O , FerreiraJJ, ThalamasC, GalitskyM, MontastrucJL: Dopamine agonists. Their role in the management of Parkinson‘s disease.Adv. Neurol.86, 301–309(2001).
  • Kaakkola S : Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson‘s disease.Drugs59(6), 1233–1250(2000).
  • Ahlskog JE , MuenterMD: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.Mov. Disord.16(3), 448–458(2001).
  • Schrag A , QuinnN: Dyskinesias and motor fluctuations in Parkinson‘s disease. A community-based study.Brain123(11), 2297–2305(2000).
  • Poewe WH , LeesAJ, SternGM: Low-dose L-dopa therapy in Parkinson‘s disease: a 6-year follow-up study.Neurology36(11), 1528–1530(1986).
  • Obeso JA , OlanowCW, NuttJG: Levodopa motor complications in Parkinson‘s disease.Trends Neurosci.23(Suppl. 10), S2–S7 (2000).
  • Schrag A , Ben-ShlomoY, BrownR, MarsdenCD, QuinnN: Young-onset Parkinson‘s disease revisited – clinical features, natural history, and mortality.Mov. Disord.13(6), 885–894(1998).
  • Schrag A : Psychiatric aspects of Parkinson‘s disease – an update.J. Neurol.251(7), 795–804(2004).
  • Schrag A , Ben-ShlomoY, QuinnN: How common are complications of Parkinson‘s disease?J. Neurol.249(4), 419–423(2002).
  • Aarsland D , LarsenJP, LimNGet al.: Range of neuropsychiatric disturbances in patients with Parkinson‘s disease.J. Neurol. Neurosurg. Psychiatr.67(4), 492–496(1999).
  • Fenelon G , MahieuxF, HuonR, ZieglerM: Hallucinations in Parkinson‘s disease: prevalence, phenomenology and risk factors.Brain123(4), 733–745(2000).
  • Meyers R : Surgical procedure for postencephalitic tremor, with notes on the physiology of premotor fibers.Arch. Neurol. Psychiatry44, 455–459(1940).
  • Spiegel EA , WycisHT, MarksM, LeeAJ: Stereotaxic apparatus for operations on the human brain.Science106, 349–350(1947).
  • Clarke RH , HorsleyVA: On a method of investigating the deep ganglia and tracts of the central nervous system (cerebellum).Br. Med. J.2, 1799–1800(1906).
  • Schaltenbrand G , WahrenW: Atlas for Stereotaxy of the Human Brain (2nd Edition). Georg Thieme Publishers, Stuttgart, Germany (1977).
  • Meyers R : Surgical experiments in the therapy of certain ‘extrapyramidal’ diseases: a current evaluation.Acta Psychiatr. Neurol. Scand. Suppl.5–40(1951).
  • Narabayashi H , OkumaY, ShikibiaS: Procaine oil blocking of the globus pallidus.Arch. Neurol. Psychiatry75, 36–48(1956).
  • Hassler R , RiechertT: Indikationen und Lokalisationsmethode der gezielten Hirnoperationen.Nervenarzt25(11), 441–447(1954).
  • Cooper IS , BravoGJ: Implications of a five-year study of 700 basal ganglia operations.Neurology8, 701–707(1958).
  • Svennilson E : Treatment of parkinsonism by stereotactic thermolesions in the pallidal region.Acta Psychiatr. Neurol. Scand.35, 358–377(1960).
  • Spiegel EA , WycisHT, SzekelyEG, AdamsJ, FlanaganM, BairdHW: Campotomy in various extrapyramidal disorders.J. Neurosurg.20, 871–881(1963).
  • Andy OJ , JurkoMF, SiasFR Jr: Subthalamotomy in treatment of parkinsonian tremor. J. Neurosurg.20, 860–870(1963).
  • Fager CA : Evaluation of thalamic and subthalamic surgical lesions in the alleviation of Parkinson‘s disease.J. Neurosurg.28, 145–149(1968).
  • Hariz MI : From functional neurosurgery to “interventional” neurology: survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson‘s disease from 1966 to 2001.Mov. Disord.18(8), 845–853(2003).
  • Speelman JD : Parkinson‘s disease and stereotaxic neurosurgery (thesis). Rodopi, Amsterdam (1991).
  • Langston JW , BallardP, TetrudJW, IrwinI: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.Science219(4587), 979–980(1983).
  • Kolata G : Monkey model of Parkinson‘s disease.Science220(4598), 705 (1983).
  • Benabid AL , PollakP, LouveauA, HenryS, de Rougemont J: Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol.50, 344–346(1987).
  • Schuurman PR , BoschDA, BossuytPMet al.: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N. Engl. J. Med.342, 461–468(2000).
  • Laitinen LV , BergenheimAT, HarizMI: Leksell‘s posteroventral pallidotomy in the treatment of Parkinson‘s disease.J. Neurosurg.76, 53–61(1992).
  • Laitinen LV , BergenheimAT, HarizMI: Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms.Stereotact. Funct. Neurosurg.58, 14–21(1992).
  • de Bie RMA , SchuurmanPR, EsselinkRAJ, BoschDA, SpeelmanJD: Bilateral pallidotomy in Parkinson‘s disease: a retrospective study.Mov. Disord.17(3), 533–538(2002).
  • Ghika J , Ghika-SchmidF, FankhauserHet al.: Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson‘s disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. J. Neurosurg.91, 313–321(1999).
  • Merello M , StarksteinS, NouzeillesMI, KuzisG, LeiguardaR: Bilateral pallidotomy for treatment of Parkinson‘s disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation.J. Neurol. Neurosurg. Psychiatr.71(5), 611–614(2001).
  • Pollak P , BenabidAL, GrossCet al.: Effects of the stimulation of the subthalamic nucleus in Parkinson disease.Rev. Neurol. (Paris)149(3), 175–176(1993).
  • Siegfried J , LippitzB: Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.Neurosurgery35, 1126–1129(1994).
  • McIntyre CC , SavastaM, Kerkerian-LeGL, VitekJL: Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both.Clin. Neurophysiol.115(6), 1239–1248(2004).
  • Brown P , MazzoneP, OlivieroAet al.: Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson‘s disease.Exp. Neurol.188(2), 480–490(2004).
  • Volkmann J , AllertN, VogesJ, WeissPH, Freund H-J, Sturm V: Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology56, 548–551(2001).
  • The Deep-Brain Stimulation For Parkinson‘s Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson‘s disease. N. Engl. J. Med.345, 956–963(2001).
  • Loher TJ , BurgunderJM, PohleT, WeberS, SommerhalderR, KraussJK: Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study.J. Neurosurg.96(5), 844–853(2002).
  • Anderson VC , BurchielKJ, HogarthP, FavreJ, HammerstadJP: Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.Arch. Neurol.62(4), 554–560(2005).
  • Fields JA , TrosterAI, WilkinsonSB, PahwaR, KollerWC: Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson‘s disease.Clin. Neurol. Neurosurg.101, 182–188(1999).
  • Ardouin C , PillonB, PeifferEet al.: Bilateral subthalamic or pallidal stimulation for Parkinson‘s disease affects neither memory nor executive functions: a consecutive series of 62 patients.Ann. Neurol.46(2), 217–223(1999).
  • Pillon B , ArdouinC, DamierPet al.: Neuropsychological changes between ‘off’ and ‘on’ STN or GPi stimulation in Parkinson‘s disease.Neurology55, 411–418(2000).
  • Rodriguez-Oroz MC , ObesoJA, LangAEet al.: Bilateral deep brain stimulation in Parkinson‘s disease: a multicentre study with 4 years follow-up. Brain128(10), 2240–2249(2005).
  • Volkmann J , AllertN, VogesJ, SturmV, SchnitzlerA, FreundHJ: Long-term results of bilateral pallidal stimulation in Parkinson‘s disease.Ann. Neurol.55(6), 871–875(2004).
  • Houeto JL , BejjaniPB, DamierPet al.: Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD.Neurology55(5), 728–730(2000).
  • Limousin P , KrackP, PollakPet al.: Electrical stimulation of the subthalamic nucleus in advanced Parkinson‘s disease.N. Engl. J. Med.339(16), 1105–1111(1998).
  • Houeto JL , DamierP, BejjaniPBet al.: Subthalamic stimulation in Parkinson disease: a multidisciplinary approach.Arch. Neurol.57(4), 461–465(2000).
  • Vesper J , KlostermannF, StockhammerF, FunkT, BrockM: Results of chronic subthalamic nucleus stimulation for Parkinson‘s disease: a 1-year follow-up study.Surg. Neurol.57(5), 306–311(2002).
  • Vingerhoets FJ , VillemureJG, TemperliP, PolloC, PralongE, GhikaJ: Subthalamic DBS replaces levodopa in Parkinson‘s disease.Neurology58, 396–401(2002).
  • Herzog J , VolkmannJ, KrackPet al.: Two-year follow-up of subthalamic deep brain stimulation in Parkinson‘s disease.Mov. Disord.18(11), 1332–1337(2003).
  • Kleiner-Fisman G , FismanDN, SimeE, Saint-CyrJA, LozanoAM, LangAE: Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.J. Neurosurg.99(3), 489–495(2003).
  • Østergaard K , SundeN, DupontE: Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson‘s disease and motor fluctuations.Mov. Disord.17(4), 693–700(2002).
  • Pahwa R , WilkinsonSB, OvermanJ, Lyons KE: Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J. Neurosurg.99(1), 71–77(2003).
  • Romito LM , ScerratiM, ContarinoMF, IacoangeliM, BentivoglioAR, AlbaneseA: Bilateral high frequency subthalamic stimulation in Parkinson‘s disease: long-term neurological follow-up.J. Neurosurg. Sci.47(3), 119–128(2003).
  • Krause M , FogelW, MayerP, KlossM, TronnierV: Chronic inhibition of the subthalamic nucleus in Parkinson‘s disease.J. Neurol. Sci.219(1–2), 119–124(2004).
  • Esselink RAJ , de Bie RM, de Haan RJ et al.: Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson‘s disease: a randomised, observer-blind, multi-centre trial. Neurology62, 201–207(2004).
  • Krack P , BatirA, Van Blercom N et al.: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson‘s disease. N. Engl. J. Med.349, 1925–1934(2003).
  • Funkiewiez A , ArdouinC, KrackPet al.: Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson‘s disease.Mov. Disord.18, 524–530(2003).
  • Funkiewiez A , ArdouinC, CaputoEet al.: Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson‘s disease.J. Neurol. Neurosurg. Psychiatr.75(6), 834–839(2004).
  • Houeto JL , MesnageV, MalletLet al.: Behavioural disorders, Parkinson‘s disease and subthalamic stimulation.J. Neurol. Neurosurg. Psychiatr.72, 701–707(2002).
  • Doshi PK , ChhayaN, BhattMH: Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson‘s disease.Mov. Disord.17(5), 1084–1085(2002).
  • Woods SP , FieldsJA, TrosterAI: Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson‘s disease: a critical review.Neuropsychol. Rev.12(2), 111–126(2002).
  • Morrison CE , BorodJC, PerrineKet al.: Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson‘s disease.Arch. Clin. Neuropsychol.19(2), 165–181(2004).
  • Alegret M , JunquéC, ValldeoriolaFet al.: Effects of bilateral subthalamic stimulation on cognitive function in Parkinson‘s disease.Arch. Neurol.58, 1223–1227(2001).
  • Saint-Cyr JA , TrepanierLL, KumarR, LozanoAM, LangAE: Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson‘s disease.Brain123(10), 2091–2108(2000).
  • Dujardin K , DefebvreL, KrystkowiakP, BlondS, DesteeA: Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson‘s disease.J. Neurol.248(7), 603–611(2001).
  • Schupbach WM , ChastanN, WelterMLet al.: Stimulation of the subthalamic nucleus in Parkinson‘s disease: a 5 year follow up. J. Neurol. Neurosurg. Psychiatr.76(12), 1640–1644(2005).
  • Rodriguez-Oroz MC , ZamarbideI, GuridiJ, PalmeroMR, ObesoJA: Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson‘s disease 4 years after surgery: double blind and open label evaluation.J. Neurol. Neurosurg. Psychiatr.75(10), 1382–1385(2004).
  • Bonnet AM , LoriaY, Saint-HilaireMH, LhermitteF, AgidY: Does long-term aggravation of Parkinson‘s disease result from nondopaminergic lesions?Neurology37(9), 1539–1542(1987).
  • Markham CH , DiamondSG: Modification of Parkinson‘s disease by long-term levodopa treatment.Arch. Neurol.43(4), 405–407(1986).
  • Krack P , PollakP, LimousinPet al.: Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson‘s disease.Brain121, 451–457(1998).
  • Krause M , FogelW, HeckAet al.: Deep brain stimulation for the treatment of Parkinson‘s disease: subthalamic nucleus versus globus pallidus internus.J. Neurol. Neurosurg. Psychiatr.70, 464–470(2001).
  • Mazzone P , BrownP, DiLazzaroVet al.: Bilateral implantation in globus pallidus internus and subthalamic nucleus in Parkinson‘s disease.Neuromodulation8(1), 1–6(2005).
  • Welter ML , HouetoJL, Tezenas du Montcel S et al.: Clinical predictive factors of subthalamic stimulation in Parkinson‘s disease. Brain125(3), 575–583(2002).
  • Pahwa R , WilkinsonSB, OvermanJ, Lyons KE: Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson‘s disease. Stereotact. Funct. Neurosurg.83(2–3), 80–83(2005).
  • Charles PD , Van Blercom N, Krack P et al.: Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology59, 932–934(2002).
  • Lang AE , WidnerH: Deep brain stimulation for Parkinson‘s disease: patient selection and evaluation.Mov. Disord.17(Suppl. 3), S94–S101 (2002).
  • Mazzone P , LozanoA, StanzionePet al.: Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson‘s disease.Neuroreport16(17), 1877–1881(2005).
  • Plaha P , GillSS: Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson‘s disease.Neuroreport16(17), 1883–1887(2005).
  • Jenkinson N , NandiD, AzizTZ, SteinJF: Pedunculopontine nucleus: a new target for deep brain stimulation for akinesia.Neuroreport16(17), 1875–1876(2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.